Pierre Delavaud joins SkyePharma from Catalent
Takes on role of executive vp of sales and business development
Delavaud has more than 17 years of experience in the pharmaceutical industry, with a strong track record in marketing, sales and global business development, of which 14 years have been with the Catalent Group.
Until recently he was vice president of sales and business development Global Pharmaceutical Softgel. Previous roles include vp of business development Europe, vp of sales and marketing Pharmaceutical Technology Services Europe and general manager of the Beinheim Softgel plant.
Axel Mueller, chief executive of SkyePharma, said: ‘Pierre’s international industry experience, combined with his impressive track record in marketing, sales and business development, will help SkyePharma to expand its early stage pipeline and attract additional partnership opportunities. He joins SkyePharma at an exciting time, with preparations for the launch of Flutiform in Europe, subject to approval, at an advanced stage and a number of interesting products in the development pipeline.’
